35 results on '"Groenink L"'
Search Results
2. Cannabidiol in anxiety research – a translational integration of preclinical and clinical studies
3. The effect of selective serotonin reuptake inhibitors on fear learning: a systematic review and meta-analysis
4. Linking Stress and Schizophrenia: A Focus on Prepulse Inhibition
5. List of Contributors, Part 2
6. Effect of early life supplementation of non-digestible oligosaccharides on brain development and behaviour in healthy mice
7. Human fear acquisition deficits in relation to genetic variants of the corticotropin-releasing hormone receptor 1 and the serotonin transporter - revisited
8. CRF1 receptor antagonists do not reverse pharmacological disruption of prepulse inhibition in rodents
9. S.12.06 Corticotropin releasing hormone and serotonin – the neuropsychopharmacology of fear learning deficit from rodents to humans
10. P.4.e.009 A translational look at the serotonin transporter and corticotropin-releasing hormone in the acquisition of adaptive fear responses
11. P.4.036 Corticotropin-releasing hormone and serotonin – the neuropsychopharmacology of fear learning deficit from rodents to humans
12. Genetic Deletion of Trace Amine 1 Receptors Reveals Their Role in Auto-Inhibiting the Actions of Ecstasy (MDMA)
13. P.4.d.003 Life-long CRF overproduction is associated with changes in functional sensitivity and gene expression of GABA-A and mGluR receptor subtypes
14. Local repeated corticotropin-releasing factor infusion exacerbates anxiety- and fear-related behavior: differential involvement of the basolateral amygdala and medial prefrontal cortex
15. Cocaine-induced changes in affective state modulate the light-enhanced startle response
16. Disrupted startle modulation in animal models for affective disorders
17. Activation of the septohippocampal system differentiates anxiety from fear in startle paradigms
18. Olfactory bulbectomy induces rapid and stable changes in basal and stress-induced locomotor activity, heart rate and body temperature responses in the home cage
19. The triple monoaminergic reuptake inhibitor DOV 216,303 has antidepressant effects in the rat olfactory bulbectomy model and lacks sexual side effects
20. SSR149415, a non-peptide vasopressin V1b receptor antagonist, has long-lasting antidepressant effects in the olfactory bulbectomy-induced hyperactivity depression model
21. P.2.09 Alterations in affective startle modulation: indicative of anhedonia?
22. Altered behavioural adaptation in mice with neural corticotrophin‐releasing factor overexpression
23. Mouse strain differences in autonomic responses to stress
24. A35 THE ROLE OF THE 5-HT1A RECEPTOR IN THE DEVELOPMENT OF ANXIETY DISORDERS
25. B79 SEX-SPECIFIC EFFECTS ON STARTLE POTENTATION FOLLOWING EARLY LIFE STRESS
26. P.2.02 The 5-HT1A and GABAA-benzodiazepine receptors: Effects in behavior and pharmacology in female 5-HT1A knockout mice
27. S.2.1 Translation of animal models to humanpsychopathology
28. Urocortin expression in the Edinger-Westphal nucleus is down-regulated in transgenic mice over-expressing neuronal corticotropin-releasing factor
29. Flesinoxan pretreatment differentially affects corticosterone, prolactin and behavioural responses to a flesinoxan challenge
30. 5-HT1AReceptor Agonist Flesinoxan Enhances Fos Immunoreactivity in Rat Central Amygdala, Bed Nucleus of the Stria Terminalis and Hypothalamus
31. Repeated flesinoxan administration in rats: Dissociation of hormonal and behavioural effects
32. 5-HT1A receptors, anxiety and stress: Behavioural, neuroendocrine and physiological interfaces
33. Abstracts of papers and posters Pharmacological Meeting
34. Abstracts of papers Pharmacological Meeting
35. Effects of cholecystokinin tetrapeptide (CCK4) on open field behaviour and potentiated startle in rats
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.